Haloperidol’s introduction in the United States: A tale of a failed trial and its consequences

References

• Advertisement for Haldol. 1974. Archives of General Psychiatry 31 (5): 732–733.
   Google Scholar
• Ban, T. A. 2006. A history of the Collegium Internationale Neuro-psychopharmacologicum (1957–2004). Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 (4):599–616. doi:10.1016/j.pnpbp.2006.01.014.
   PubMed Web of Science ®Google Scholar
• Carlson, R. P. 2010. Life and scientific career of C. Gordon Van Arman, Ph.D. Inflammation Research 59 (3):239–42. doi:10.1007/s00011-009-0148-x.
   PubMed Web of Science ®Google Scholar
• Cleghorn, R. A. 1984. The emergence of psychiatry at McGill. The Canadian Journal of Psychiatry 29 (7):551–56. doi:10.1177/070674378402900702.
   PubMed Web of Science ®Google Scholar
• Delay, J. P., T. Pichot, T. Lemperiere, and B. Elissalde. 1960. L’action de l’haloperidol dans les psychoses. Acta Neurologica et Psychiatrica Belgica 60:21–38.
   PubMedGoogle Scholar
• Denber, H. C. 1955. Appraisal of drug reactions. Journal of the American Medical Association 158 (7):586–87. doi:10.1001/jama.1955.02960070062021.
   Web of Science ®Google Scholar
• Denber, H. C. 1958. Ineffectiveness of mepazine (pacatal). American Journal of Psychiatry 114 (7):656. doi:10.1176/ajp.114.7.656.
   PubMed Web of Science ®Google Scholar
• Denber, H. C. 1963. Group process in a state hospital. American Journal of Orthopsychiatry 33 (5):900–11. doi:10.1111/j.1939-0025.1963.tb01053.x.
   PubMed Web of Science ®Google Scholar
• Denber, H. C. 1972. Psychodynamic observations of the research worker in psychiatry: Further considerations. Canadian Psychiatric Association Journal 17 (6_suppl2):83–88. doi:10.1177/07067437720176S215.
   Google Scholar
• Denber, H. C., and E. G. Bird. 1957. Chlorpromazine in the treatment of mental illness. IV. Final results with analysis of data on 1,523 patients. American Journal of Psychiatry 113 (11):972–78. doi:10.1176/ajp.113.11.972.
   PubMed Web of Science ®Google Scholar
• Denber, H. C., and J. Collard. 1962. Différences de bioréactivité au Haloperidol entre deux groupes de psychothiques, américain et européen. Acta Neurologica et Psychiatrica Belgica 62:577–88.
   PubMedGoogle Scholar
• Denber, H. C., and S. Merlis. 1954. A note on some therapeutic implications of the mescaline induced state. The Psychiatric Quarterly 28 (1):635–40. doi:10.1007/BF01567079.
   Google Scholar
• Denber, H. C., P. Rajotte, and D. Kauffman. 1959a. Clinical experiences with a new phenothiazine. American Journal of Psychiatry 115 (12):1116–17. doi:10.1176/ajp.115.12.1116.
   PubMed Web of Science ®Google Scholar
• Denber, H. C., P. Rajotte, and D. Kauffman. 1959b. Problems in evaluation of R-1625. American Journal of Psychiatry 116 (4):356–57. doi:10.1176/ajp.116.4.356.
   PubMed Web of Science ®Google Scholar
• Denber, H. C., P. Rajotte, and E. Ross. 1960. Some observations on the chemotherapy of depression: Results with ‘Taractan’. Comprehensive Psychiatry 1 (5):308–312. doi:10.1016/S0010-440X(60)80006-5.
   Web of Science ®Google Scholar
• Denber, H. C., D. N. Teller, P. Rajotte, and D. Kauffman. 1962. Studies on mescaline. XIII. The effect of prior administration of various psychotropic drugs on different biochemical parameters: A preliminary report. Annals of the New York Academy of Sciences 96 (1):14–36. doi:10.1111/j.1749-6632.1962.tb50098.x.
   PubMed Web of Science ®Google Scholar
• Denham, J., and D. Carrick. 1961. Therapeutic value of thioproperazine and the importance of the associated neurological disturbances. Journal of Mental Science 107 (447):326–45. doi:10.1192/bjp.107.447.326.
   PubMed Web of Science ®Google Scholar
• Divry, P., J. Bobon, and J. Collard. 1958. Le R1625, nouvelle thérapeutique symptomatique de l’agitation psychomotrice. Acta Neurologica et Psychiatrica Belgica 58 (10):878–88.
   PubMedGoogle Scholar
• Gauchet, M., and G. Swain. 2012. Madness and democracy. Princeton, NJ: Princeton University Press.
   Google Scholar
• Gerle, B. 1960. Clinical trials of R 1625. Acta Neurologica et Psychiatrica Belgica 60:70–74.
   PubMedGoogle Scholar
• Granger, B., and S. Albu. 2005. The haloperidol story. Annals of Clinical Psychiatry 17 (3):137–40. doi:10.3109/10401230591002048.
   PubMedGoogle Scholar
• Healy, D. 1998a. The psychopharmacologists I: Interviews. London: Arnold.
   Google Scholar
• Healy, D. 1998b. The psychopharmacologists II: Interviews. London and New York: Altman.
   Google Scholar
• Healy, D. 2002. The creation of psychopharmacology. Cambridge, MA: Harvard University Press.
   Google Scholar
• Hoch, P., J. Cattell, and H. Pennes. 1952. Effects of mescaline and lysergicacid (d-LSD-25). American Journal of Psychiatry 108 (8):579–84. doi:10.1176/ajp.108.8.579.
   PubMed Web of Science ®Google Scholar
• Janssen, P. 1965. The evolution of the butyrophenones, haloperidol and trifluperidol, from meperidine-like 4-phenylpiperidines. In International review of neurobiology, ed. C. C. Pfeiffer and J. R. Smythies, vol. 8, 221–63. New York and London: Academic Press.
   Google Scholar
• Knauer, A., and W. Maloney. 1913. A preliminary note on the psychic action of mescalin, with special reference to the mechanism of visual hallucinations. Journal Nervous and Mental Disease 40 (7):425–36. doi:10.1097/00005053-191307000-00001.
   Google Scholar
• Kramer, M. 1961. Some problems for international research suggested by observations on differences in first admission rates to the mental hospitals of England and Wales and of the United States. In Proceedings of the Third World Congress of Psychiatry, Vol. 3. Montreal, Canada: University of Toronto Press/McGill University Press.
   Google Scholar
• Kübler-Ross, E. 1998. The wheel of life: A memoir of living and dying. New York: Simon and Schuster.
   Google Scholar
• López-Muñoz, F., and C. Alamo. 2009. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Research Bulletin 79 (2):130–41. doi:10.1016/j.brainresbull.2009.01.005.
   PubMed Web of Science ®Google Scholar
• López-Muñoz, F., C. Alamo, E. Cuenca, W. Shen, P. Clervoy, and G. Rubio. 2005. History of the discovery and clinical introduction of chlorpromazine. Annals of Clinical Psychiatry 17 (3):113–35. doi:10.1080/10401230591002002.
   PubMedGoogle Scholar
• Meszaros, A. F., and D. L. Gallagher. 1958. Measuring indirect effects of treatment on chronic wards. Diseases of the Nervous System 19 (4):167–72.
   PubMedGoogle Scholar
• Metzl, J. M. 2010. The protest psychosis: How schizophrenia became a black disease. Boston, MA: Beacon Press.
   Google Scholar
• Obituaries. April 15, 1967. Canadian Medical Association Journal 96:182.
   Web of Science ®Google Scholar
• Ravina, E. 2011. The evolution of drug discovery: From traditional medicines to modern drugs. New York: Wiley.
   Google Scholar
• Reed, C. August 31, 2004. Elisabeth Kubler-Ross. The Guardian.
   Google Scholar
• Rossum, J. 1966. The significance of dopamine-receptor blockade for the action of neuroleptic drugs. In Neuro-psycho-pharmacology, ed. B. H, 321–29. Amsterdam: Excerpta Medica Foundation.
   Google Scholar
• Sarwer Foner, G. 1966. A note on the origins and past history of the nameless psychiatric research group sometimes called “the-group-without-A-name.” Canadian Psychiatric Association Journal 11 (1_suppl):7–8. doi:10.1177/070674376601101s03.
   Google Scholar
• Seabra-Dinis, J., and M. Silva. 1960. L’emploi thérapeutique d’un nouveau médicament non phénothiazinique, le R 1625 ou halopéridol, chez des malades mentaux d’évolution prolongée. Acta Neurologica et Psychiatrica Belgica 60:123.
   PubMedGoogle Scholar
• Seeman, M. V. 2004. Therapy in the gray zone: Psychiatry recalled. Canadian Medical Association Journal 171 (12):1477–79. doi:10.1503/cmaj.1040002.
   Web of Science ®Google Scholar
• Seeman, M. V. 2017. The 1960s in North American psychiatry. Hektoen International. https://hekint.org/2017/11/16/1960s-north-american-psychiatry/.
   Google Scholar
• Shorter, E. 2005. A historical dictionary of psychiatry. Oxford: Oxford University Press.
   Google Scholar
• Strous, R. D., A. A. Opler, and L. A. Opler. 2016. Reflections on “Emil Kraepelin: Icon and reality.” American Journal of Psychiatry 17 3 (3):300–301. doi:10.1176/appi.ajp.2016.15111414.
   Google Scholar